Tataranu Ligia Gabriela
Department of Neurosurgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Department of Neurosurgery, Bagdasar-Arseni Emergency Clinical Hospital, 041915 Bucharest, Romania.
Int J Mol Sci. 2025 Apr 15;26(8):3717. doi: 10.3390/ijms26083717.
Arising from the anterior lobe of the hypophysis, pituitary neuroendocrine tumors (PitNETs), previously known as pituitary adenomas, constitute an intricate and heterogeneous entity. Although they are defined as benign pathology, these tumors can often invade neighboring structures and demonstrate aggressive behavior. The continuous advancement of molecular biology has begun to shed light on the genetic mutations behind the development and evolution of this pathology, providing a better understanding. Notwithstanding, the rising occurrence in recent decades can mainly be attributed to advanced diagnostic techniques; however, these tumors continue to increase in prevalence and incidence, creating a heavy burden on healthcare systems. Consequently, the need for further studies is dire, primarily due to a lack of tailored therapeutic approaches. Thus, this article aims to offer a brief overview of the molecular biology behind these complex tumors to contribute, even on a small scale, to more comprehensive care.
垂体神经内分泌肿瘤(PitNETs)起源于垂体前叶,以前被称为垂体腺瘤,是一种复杂的异质性实体。尽管它们被定义为良性病变,但这些肿瘤常常会侵犯邻近结构并表现出侵袭性。分子生物学的不断发展已开始揭示这种病变发生和演变背后的基因突变,增进了人们的了解。尽管如此,近几十年来发病率的上升主要归因于先进的诊断技术;然而,这些肿瘤的患病率和发病率仍在持续上升,给医疗系统带来了沉重负担。因此,迫切需要进一步开展研究,主要是因为缺乏针对性的治疗方法。因此,本文旨在简要概述这些复杂肿瘤背后的分子生物学,即便只是在小范围内,也能为更全面的治疗做出贡献。